LexisNexis® Legal Newsroom
Pfizer Ordered To Pay $47.3M To Health Insurer In Neurontin RICO Trial

BOSTON — (Mealey’s) A Massachusetts federal jury on March 25 awarded $47.3 million to the Kaiser Foundation after finding that Pfizer Inc. engaged in racketeering and unfair competition through its off-label marketing of Neurontin ( In Re: Neurontin Marketing, Sales Practices, and Products...

3rd Circuit: Humana Can Sue GSK For Reimbursement For Avandia-Related Expenses

PHILADELPHIA - (Mealey's) Medicare Advantage provider Humana Medical Plan Inc. is allowed under Medicare law to seek reimbursement from GlaxoSmithKline PLC (GSK) for the costs of treating insurance customers who were injured by GSK's Avandia diabetes drug, a unanimous Third Circuit U.S. Court...

William A. Ruskin: Ex Parte Communication With Plaintiff's Prescribing Physician

By William A. Ruskin In product liability litigation, a single tactical advantage may determine whether the case is won or lost. Often, being able to anticipate an issue before it arises and addressing it in the Case Management Order may be critical. This is particularly the case in pharmaceutical...

Toyota Agrees To Fund Settlement Of Unintended Acceleration Cases Worth Up To $1.4 Billion

Attorney representing Toyota owners calls settlement "extraordinarily hard-fought, exceptionally far-reaching" LOS ANGELES - The attorneys representing Toyota owners who claim that their vehicles are prone to sudden, unexplained acceleration on Dec. 26 announced that Toyota has agreed to...

Yasmin, Yaz Gallbladder Cases Settled For $24 Million By Bayer; Payouts Are $2,000-$3,000

EAST ST. LOUIS, Ill. — (Mealey’s) Bayer HealthCare Pharmaceuticals Inc. will pay $24 million to resolve claims of plaintiffs who allege that they developed gallbladder disease or underwent gallbladder surgery as a result of using Yasmin or Yaz drospirenone-containing birth control pills,...